Results 201 to 210 of about 2,590,210 (272)

Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases. [PDF]

World J Surg Oncol
Hayler R, Garrett C, Guo J, Barat S, Sarofim M, Wijayawardana R, Ahmadi N, Liauw W, Morris DL.   +8 more
europepmc   +1 more source

Real-world risk factors for incomplete cytoreduction in peritoneal carcinomatosis patients scheduled for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

World J Surg Oncol
Chen CY, Lee LW, Huang TH, Ou YC, Hung CH, Lung J, Liao YS, Wang TY, Yang LY.   +8 more
europepmc   +1 more source

The use of ROTEM in Detection of Coagulopathy and Altered Hemostasis in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]

J Surg Oncol
Mashat A, Taqi K, Parapini M, Chen J, Trudeau J, Wilson J, Hamilton TD, MacNeill AJ.   +7 more
europepmc   +1 more source

Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit? [PDF]

Surg Endosc
Sparkman BK, Freudenberger DC, Vudatha V, Trevino JG, Khader A, Fernandez LJ.   +5 more
europepmc   +1 more source

Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer.

JAMA Netw Open
González Sánchez S, García Fernández J, Cascales-Campos PA, Gonzalez Gil A, Manzanedo I, Pereira Perez F, Díaz Gómez D, González-de Pedro C, Asensio Diaz E, Pacheco Sanchez D, Prada-Villaverde A, Jaén Torrejimeno I, Lacueva J, Caravaca-Garcia I, Torres-Melero J, Sanchez-García S, Díaz Reques E, Ramírez Plaza C, Gutiérrez-Calvo A, González Bayón L, Morales-Soriano R, López-Mozos F, Bjelic L, Galindo Álvarez J, Marcello Fernandez ME, Turienzo Santos E, Titos García A, Álvarez Seoane R, Artiles Armas M, Garaulet ET, Villarejo Campos P, Boldó Roda E, Rihuete Caro C, García Fadrique A, Arjona-Sánchez Á, REGECOP collaborators.   +35 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.

Journal of Clinical Oncology, 2023
PURPOSE To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy.
R. Bristow, Rafael S. Tomacruz, D. Armstrong, E. Trimble, F. Montz   +4 more
semanticscholar   +1 more source

Cytoreductive Surgery

2022
Alexander B. Olawaiye, Ritu Salani
  +8 more sources

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).

British Journal of Surgery, 2021
BACKGROUND The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. The prognosis for patients with peritoneal metastases remains poor and the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is ...
P. Bonnot, A. Lintis, F. Mercier, N. Benzerdjeb, G. Passot, M. Pocard, B. Meunier, J. Bereder, K. Abboud, F. Marchal, F. Quénet, D. Goéré, S. Msika, C. Arvieux, N. Pirró, R. Wernert, P. Rat, J. Gagnière, J. Lefèvre, T. Courvoisier, R. Kianmanesh, D. Vaudoyer, M. Rivoire, P. Meeus, L. Villeneuve, G. Piessen, O. Glehen   +26 more
semanticscholar   +1 more source